MIT Technology Review Subscribe

Most Americans Think Editing the Human Genome Is Okay

In a survey published today in Science, two-thirds of people polled believe that using gene-editing technology to modify human cells was “acceptable.” The survey (PDF, sub required), which was carried out by researchers at the University of Wisonsin in Madison and Temple University, presented 1,600 people with various hypothetical use cases for genome editing technology. For example, it asked how people felt about modifying DNA in human germ-line cells, which can be passed down to future generations, versus genes in somatic cells, which aren’t.

In general, most respondents frowned on germ-line editing, with just 26 percent of people in support of it, versus 39 percent endorsing editing of somatic cells. That fits with the results of previous surveys, which have shown that people don’t generally like the idea of creating “designer babies” or genetically enhanced humans that pass down their artificial advantages to their offspring.

Advertisement

Opinions were much more favorable toward people editing their own bodies—59 percent of survey participants said that would be fine, whether it meant altering DNA to cure a disease, or even for some kind of enhancement.

This story is only available to subscribers.

Don’t settle for half the story.
Get paywall-free access to technology news for the here and now.

Subscribe now Already a subscriber? Sign in
You’ve read all your free stories.

MIT Technology Review provides an intelligent and independent filter for the flood of information about technology.

Subscribe now Already a subscriber? Sign in

For now, such a scenario remains largely academic, but it won’t be for long. As we reported last week, U.S. researchers are already testing gene-editing techniques on human embryos as a way to fix serious disease. And in extreme cases, some cancer patients have their immune cells genetically modified to fight tumors. As such technologies continue to develop, it will be important to keep an eye on how the public receives them. 

This is your last free story.
Sign in Subscribe now

Your daily newsletter about what’s up in emerging technology from MIT Technology Review.

Please, enter a valid email.
Privacy Policy
Submitting...
There was an error submitting the request.
Thanks for signing up!

Our most popular stories

Advertisement